Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT VIII in connection with the acquisition of Schülke & Mayr GmbH
Mandate

Vinge advises EQT VIII in connection with the acquisition of Schülke & Mayr GmbH

September 29, 2020 EU, Competition and Regulatory

Vinge has advised EQT VIII on the merger control aspects of EQT VIII’s acquisition of Schülke & Mayr GmbH, a provider of infection prevention solutions. The acquisition was notified to, inter alia, the European Commission.

Vinge’s team consisted primarily of Emma Johansson and Johan Wahlbom.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026